Finance 28 May 2026

Radware Drops 3% After Shareholder Vote
····

Radware Drops 3% After Shareholder Vote

Radware shareholders approved all three proposals at the May 25 annual meeting, the company said Wednesday. Shares closed down 3% at $29.00, below the 52-week high. First-quarter revenue rose 11% to $79.8 million, with cloud annual recurring revenue up 23%. Americas revenue climbed 40%, while EMEA fell 11%.
May 28, 2026
Sportradar shares take a hit after latest analyst move
·····

Sportradar shares take a hit after latest analyst move

JPMorgan downgraded Sportradar Group AG to Neutral from Overweight and cut its price target to $16 from $26. Shares closed Wednesday at $12.89 on Nasdaq, down 0.8%, and have fallen about 46% this year. The company faces scrutiny after short-seller claims and a securities lawsuit. First-quarter revenue rose 11% to 347 million euros, but Sportradar posted a 6 million euro loss.
May 28, 2026
Next Technology Stock: NXTT’s Bitcoin Bet Is Back In Focus Before Thursday’s Open
····

Next Technology Stock: NXTT’s Bitcoin Bet Is Back In Focus Before Thursday’s Open

Next Technology last traded at $1.34 before Thursday’s open, after closing up 3.1% Wednesday. The company held about 5,833 bitcoin at March 31, reporting a $126.5 million fair-value loss on digital assets and a first-quarter net loss of $105.9 million. Cash rose to $159.7 million after a $157 million share sale in March. NXTT had 76.3 million shares outstanding as of April 29.
May 28, 2026
·····

Xerox pops after 15 million-share filing seen as turnaround signal

C4 Therapeutics shares traded at $3.74 before the Nasdaq open on May 28, holding gains after a 7.16% rise the prior session. The move comes as investors await cemsidomide updates at ASCO and EHA meetings. C4 reported $268.3 million in cash at March 31 and a narrowed Q1 net loss. The company expanded its Roche partnership in April, securing a $20 million upfront payment.
May 28, 2026
Rail Vision Stock Slides Before the Bell as Tiny AI Rail Bet Faces Fresh Test
····

Rail Vision Stock Slides Before the Bell as Tiny AI Rail Bet Faces Fresh Test

Rail Vision Ltd. shares fell 2.1% to $4.65 in thin pre-market trading Thursday, after dropping 4.6% in the prior session. The stock remains near recent lows and has not issued a new company update since May 20, when it announced a quantum AI dataset integration by its Quantum Transportation unit. RVSN closed at $6.07 on May 19 and has traded between $3.66 and $29.57 over the past year.
May 28, 2026
Imunon Shares Trade Early After CEO Gets Stock Grant
····

Imunon Shares Trade Early After CEO Gets Stock Grant

Imunon shares rose 3.5% to $2.38 in thin pre-market trading Thursday after an SEC filing showed CEO Stacy Lindborg received 1,491 shares instead of part of her cash salary. The company has warned of “substantial doubt” about its ability to continue operating. Only 531 shares changed hands pre-market. Imunon’s main drug, IMNN-001, remains in Phase 3 trials for advanced ovarian cancer.
May 28, 2026
Atlas Lithium Stock Near $4 Before Shareholder Vote: Why ATLX Traders Are Watching Today
····

Atlas Lithium Stock Near $4 Before Shareholder Vote: Why ATLX Traders Are Watching Today

Atlas Lithium shares held near $4.15 in early U.S. trading ahead of its annual shareholder meeting at 10:00 a.m. ET. Investors are focused on progress at the Neves lithium project in Brazil, where plant assembly contractor Alfa Engenharia was hired this month. The company expects Neves to produce 146,000 tonnes of lithium concentrate annually. One Series A preferred share holds 51% of voting power at the meeting.
May 28, 2026
NewAmsterdam Pharma Stock Rises as Fresh Filing Puts Its $4.3 Billion Drug Bet in Focus
····

NewAmsterdam Pharma Stock Rises as Fresh Filing Puts Its $4.3 Billion Drug Bet in Focus

NewAmsterdam Pharma shares rose 1.3% to $36.56 Wednesday after Chief Accounting Officer Louise Frederika Kooij exercised and sold 65,000 shares, according to a Form 4 filing. A separate Form 144 listed a proposed sale of 210,000 shares for Kooij. The company awaits key regulatory decisions on its cholesterol drug obicetrapib later this year. NewAmsterdam reported a first-quarter net loss of $48.4 million.
May 28, 2026
Capitol Federal Stock Nears a 52-Week High as Traders Watch Margins, Buybacks
····

Capitol Federal Stock Nears a 52-Week High as Traders Watch Margins, Buybacks

Capitol Federal Financial shares rose to $7.80 in premarket trading Thursday after closing at $7.77, near a 52-week high. The Topeka-based bank reported fiscal Q2 net income of $20.1 million and a net interest margin of 2.24%. Commercial loans increased $39.1 million to $2.32 billion. The company repurchased 3.08 million shares and declared an 8.5-cent dividend.
May 28, 2026
Paloma Acquisition Shares Stay Under $10 With Metals SPAC Yet to Announce Deal
····

Paloma Acquisition Shares Stay Under $10 With Metals SPAC Yet to Announce Deal

Paloma Acquisition Corp I Class A shares traded at $9.86 before Thursday’s Nasdaq open, below the typical $10 SPAC mark. The company, a cash shell with $165.1 million in its trust as of March 31, has not reported operating revenue or named a merger target. Paloma raised $150 million in its February IPO and is seeking metals deals amid a surge in mining listings. Warrants last quoted at $0.42.
May 28, 2026
MercadoLibre Up After Earnings, One Key Metric Keeps Focus
····

MercadoLibre Up After Earnings, One Key Metric Keeps Focus

MercadoLibre shares rose 2.9% to $1,696.17 in pre-market trading Thursday, valuing the company at about $86 billion. First-quarter net revenue surged 49% to $8.8 billion, but net income fell 15.6% to $417 million as operating margin slipped to 6.9%. Management said the margin squeeze is intentional, citing heavy investment in commerce and fintech. Brazil led growth, with items sold up 56% after shipping changes.
May 28, 2026
DNA X Stock Looks at Nasdaq Deadline After Latest Financing
····

DNA X Stock Looks at Nasdaq Deadline After Latest Financing

DNA X said Nasdaq will delist its shares after the company fell short of stockholders’ equity rules, posting a $983,000 deficit for the March quarter. The company plans to request a hearing by May 29 to halt suspension as it appeals. DNA X shares last traded at $4.07 in premarket, valuing the firm at about $5.1 million. The company also announced a $3.05 million convertible note financing.
May 28, 2026
NewHold Investment Corp IV Stock Trades Near High After Sister SPAC Deal Draws Attention to NHIVU
····

NewHold Investment Corp IV Stock Trades Near High After Sister SPAC Deal Draws Attention to NHIVU

NewHold Investment Corp IV units traded at $10.12 early Thursday, about 1.2% above their April IPO price. The SPAC remains a cash shell with no announced target. Trading occurred before Nasdaq’s regular session, which was set to open at 9:30 a.m. ET. A separate $2.4 billion merger between NewHold III and nuclear firm newcleo was recently disclosed.
May 28, 2026
Carter Bankshares rally cools for now as market looks for next move
····

Carter Bankshares rally cools for now as market looks for next move

Carter Bankshares closed down 1.9% at $26.84 Wednesday, reversing part of a recent rally that brought shares near a 52-week high. Trading volume fell to 217,125 shares from 254,683 the day before. Executive vice president Jane Ann Davis sold 261 shares at $26.95 on May 21, leaving her with 13,723 shares. Carter reported first-quarter net income of $85.8 million after selling a large nonperforming loan.
May 28, 2026
SoundHound AI: $300M Share Sale Looms, $8 Level Back in Play for SOUN
·····

SoundHound AI: $300M Share Sale Looms, $8 Level Back in Play for SOUN

SoundHound AI shares last traded at $8.08 in early premarket Thursday, following a filing reviving its $300 million share sale plan and showing pro forma Q1 revenue of $101.2 million with LivePerson. The company posted a Q1 net loss of $25.0 million. Investors remain concerned about dilution and ongoing losses. SoundHound’s market cap stands near $3.47 billion.
May 28, 2026
1 2 3 4 5 … 209

Stock Market Today

  • Bell Potter Sees 36% Upside in Select Harvests Shares on ASX 300
    May 28, 2026, 6:52 PM EDT. Select Harvests Ltd (ASX: SHV) shares rose 8% to $3.90 after Bell Potter maintained a buy rating with a $5.30 target price, implying 36% upside over 12 months. Despite first-half FY2026 earnings below forecasts due to timing of third-party processing and value-added products (VAP) revenue, underlying net profit after tax (NPAT) rose 8% year-on-year to A$29.1 million. Bell Potter highlighted a crop forecast of 28,000-31,000 tonnes for FY26, share buyback of up to 10%, resumption of dividends, and plans to expand processing capacity to 65,000 tonnes, targeting A$700 million revenue by FY2030. The broker noted tightening almond supply in California supports a favorable pricing environment through FY26-28, underpinned by cost controls and growth initiatives.